All Trading Information are 15 minutes delayed
chart  EGX30  13,975.33  1.44 % chart   EGX70  605.44  0.3 % Traded Value (M)   291.37    Traded Volume (M)   88.70   86 16 49 151
Heliopolis Housing   1.89 %  chart 21.51  chart  Egyptian Chemical Industries (Kima)   2.43 %  chart 5.05  chart  Global Telecom Holding   0 %  chart 4.68  chart  Arabia Investments Holding   4.4 %  chart 0.593  chart  Arab Cotton Ginning   2.15 %  chart 1.806  chart  Cairo For Investment And Real Estate Development   -2.52 %  chart 10.83  chart  ELSWEDY ELECTRIC   2.18 %  chart 14.5  chart  Alexandria Mineral Oils Company   3.72 %  chart 4.74  chart  Palm Hills Development Company   2.04 %  chart 2.5  chart  Medinet Nasr Housing   2.03 %  chart 6.04  chart  Pioneers Holding   2.88 %  chart 6.43  chart  Eastern Company   4.79 %  chart 17.06  chart  Telecom Egypt   3.5 %  chart 13.61  chart  Six of October Development & Investment (SODIC)   2.23 %  chart 13.77  chart  Commercial International Bank (Egypt)   1.23 %  chart 70.7  chart  Emaar Misr for Development   1.58 %  chart 3.21  chart  Juhayna Food Industries   0 %  chart 11.5  chart  Egyptian Iron & Steel   2.88 %  chart 3.21  chart  GB AUTO   0.25 %  chart 4.01  chart  Citadel Capital - Common Shares   2.06 %  chart 3.46  chart  Sarwa Capital Holding   0 %  chart 5.99  chart  Arab Co. for Asset Management And Development   2.18 %  chart 2.34  chart  Oriental Weavers   1.27 %  chart 9.59  chart  Egyptian for Tourism Resorts   1.51 %  chart 1.888  chart  Egyptian Financial Group-Hermes Holding Company   0.74 %  chart 16.31  chart  Orascom Investment Holding   7.47 %  chart 0.561  chart  T M G Holding   0 %  chart 10.5  chart  Ezz Steel   3.24 %  chart 12.41  chart  Egyptian Kuwaiti Holding   0.07 %  chart 1.475  chart  Orascom Development Egypt   1.92 %  chart 6.36  chart 

RIVA PHARMA (RIVA.CA) Reports 3 Months Results (NILEX) Finanical Statements - 5/15/2019 2:12 PMArabic

Company Name : RIVA PHARMA
ISIN Code : EGS384N2C016
Currency : $
F/S Period : From 01/01/2019 To 31/03/2019
Net Loss : 187,817
F/S Period: From 01/01/2018 To 31/03/2018
Net Comparative Profit : 148,134
Audit Status : Reviewed
Source : RIVA PHARMA

The Financial Statements (6,978 KB)


Market is Open